SNYR Stock Analysis: Buy, Sell, or Hold?
SNYR - Synergy CHC Corp. Common Stock
$1.87
0.03 (1.63%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Get Alerted When SNYR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
4 traders called SNYR this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SNYR shows positive signals but monitor for confirmation. Market pricing in 0.8% decline. Moderate conviction.
💡 BUY OPPORTUNITY: SNYR shows positive signals but monitor for confirmation. Market pricing in 0.8% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$3.00
Based on 9.4% avg growth
INTRINSIC VALUE TODAY
$1.86
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SNYR is currently trading at $1.87, which is considered fair relative to its 30-day fair value range of $1.80 to $1.90. The stock's valuation (Forward PE: 6.0) is in line with its historical norms (6.2). Remarkably, the market is currently pricing in an annual earnings decline of 0.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SNYR is in a strong downtrend. Immediate support is located at $1.70, while resistance sits at $2.15.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.00 (+274.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SNYR is in a strong downtrend. Immediate support is located at $1.70, while resistance sits at $2.15.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.00 (+274.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$1.80 -
$1.90
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 274.3% below Wall St target ($7.00)
Fair Price Analysis
30-Day Fair Range
$1.80 -
$1.90
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$1.70
Resistance Level
$2.15
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
6.03
Wall Street Target
$7.00
(+274.3%)
Revenue Growth (YoY)
12.4%
Earnings Growth (YoY)
-90.6%
Profit Margin
7.5%
Valuation Discount vs History
-0.8% cheaper
PE vs Historical
6.0 vs 6.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.8%
(market-implied from PE analysis)
1-Year Target
$1.86
(-1%)
2-Year Target
$1.84
(-2%)
3-Year Target
$1.83
(-2%)
3-Yr Target (if PE normalizes)
(PE: 6→6)
$1.88
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 14.8%)
$10.46
(+460%)
Base:
(SPY PE: 6.0, Growth: 14.8%)
$2.83
(+51%)
Bear:
(PE: 5.1, Growth: 14.8%)
$2.41
(+29%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (7x PE), but valuation improves significantly next year (6x PE) as earnings recover.
Trailing PE: 6.50 | Current EPS (TTM): $0.28
Bull Case
$2.22
(+19%)
Analyst growth 10.7%, PE expands to 7.2
Base Case
$2.02
(+8%)
Market implied 10.7%, PE stable at 6.5
Bear Case
$1.24
(-34%)
Severe decline -20.0%, PE contracts to 5.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.0 to 6.2
Stabilization Target:
$1.92
(+2.8%)
PE Expansion Potential:
+2.8%
Last updated: January 31, 2026 9:40 PM ET
Data refreshes hourly during market hours. Next update: 10:40 PM
Data refreshes hourly during market hours. Next update: 10:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNYR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$942 | 60 HOLD |
|
CAH
Cardinal Health Inc |
BUY
17 analysts |
$230 | 66 BUY |
|
COR
Cencora Inc. |
BUY
17 analysts |
$397 | 65 BUY |
|
HSIC
Henry Schein Inc |
HOLD
16 analysts |
$78 | 50 HOLD |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 54 HOLD |
Advanced SNYR Option Strategies
Professional options setups generated by AI based on today's SNYR price and gamma walls.
